Tycel Phillips, MD, City of Hope, Duarte, CA, provides an overview of the prognostic tools used for patients with follicular lymphoma (FL) and highlights the need to refine these tools to identify patients with high-risk disease. Dr Phillips also talks on treatment approaches available for patients with FL and addresses the lack of therapies targeted towards specific mutations in this disease. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.